1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Synthetic Biology Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Synthetic Biology Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increasing Investments in Synthetic Biology owing to various start-ups offer solutions for difficult microbial systems
5.2 Market Opportunities
- 5.2.1 Collaboration between companies so they can collaborate inter-disciplinary globally between synthetic biologists, policymakers, researchers, and industry
5.3 Future Trends
- 5.3.1 Rising Number of Start-Ups
5.4 Impact of Drivers and Restraints
6. North America Synthetic Biology Market Regional Analysis
6.1 North America Synthetic Biology Market Overview
6.2 North America Synthetic Biology Market Revenue 2019-2028 (US$ Million)
6.3 North America Synthetic Biology Market Forecast Analysis
7. North America Synthetic Biology Market Analysis – by Products
7.1 Enzymes
- 7.1.1 Overview
- 7.1.2 Enzymes: North America Synthetic Biology Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Chassis Organisms
- 7.2.1 Overview
- 7.2.2 Chassis Organisms: North America Synthetic Biology Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Oligonucleotides
- 7.3.1 Overview
- 7.3.2 Oligonucleotides: North America Synthetic Biology Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Xeno-Nucleic Acids
- 7.4.1 Overview
- 7.4.2 Xeno-Nucleic Acids: North America Synthetic Biology Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Synthetic Biology Market Analysis – by Technology
8.1 Measurement & Modeling
- 8.1.1 Overview
- 8.1.2 Measurement & Modeling: North America Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Cloning & Sequencing
- 8.2.1 Overview
- 8.2.2 Cloning & Sequencing: North America Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Genome Engineering
- 8.3.1 Overview
- 8.3.2 Genome Engineering: North America Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Gene Synthesis
- 8.4.1 Overview
- 8.4.2 Gene Synthesis: North America Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Nanotechnology
- 8.5.1 Overview
- 8.5.2 Nanotechnology: North America Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Synthetic Biology Market Analysis – by Application
9.1 Medical Applications
- 9.1.1 Overview
- 9.1.2 Nanotechnology: North America Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Industrial Applications
- 9.2.1 Overview
- 9.2.2 Nanotechnology: North America Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Food and Agriculture
- 9.3.1 Overview
- 9.3.2 Nanotechnology: North America Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Environmental Applications
- 9.4.1 Overview
- 9.4.2 Nanotechnology: North America Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Synthetic Biology Market – North America Analysis
10.1 North America
- 10.1.1 North America Synthetic Biology Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.1.1.1 North America Synthetic Biology Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 US: North America Synthetic Biology Market Breakdown, by Products
- 10.1.1.1.2 US: North America Synthetic Biology Market Breakdown, by Technology
- 10.1.1.1.3 US: North America Synthetic Biology Market Breakdown, by Application
- 10.1.1.2 Canada:
North America Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Canada: North America Synthetic Biology Market Breakdown, by Products
- 10.1.1.2.2 Canada: North America Synthetic Biology Market Breakdown, by Technology
- 10.1.1.2.3 Canada: North America Synthetic Biology Market Breakdown, by Application
- 10.1.1.3 Mexico :
North America Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Mexico : North America Synthetic Biology Market Breakdown, by Products
- 10.1.1.3.2 Mexico : North America Synthetic Biology Market Breakdown, by Technology
- 10.1.1.3.3 Mexico : North America Synthetic Biology Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Synthetic Biology Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Agilent Technologies, Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Amyris
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Codexis
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Genscript Biotech corporation
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Integrated DNA Technologies
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Merck KGaA
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 New England Biolabs
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Novozymes A/S
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Thermo Fisher Scientific
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Twist Bioscience
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights